caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1790944114

T KinghamM.D.

Surgical OncologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where T Kingham's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MANNELLI, LORENZO2754
Kinh Gian Do
Diagnostic Radiology · New York, NY
1940
Michael Baum
Cardiology · New York, NY
1861
Scott Gerst
Diagnostic Radiology · New York, NY
1542
Jinru Shia
Pathology · New York, NY
1553
Howard Weinstein
Cardiology · New York, NY
1246
Florence Moses Grant
Anesthesiology · Scranton, PA
1257
FRUAUFF, ARTHUR1129
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
1132
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
310
Unique beneficiaries
—
Total services
355
Distinct HCPCS
8
Medicare payment
$57K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 112 Surgical Oncology providers in NY — above median (cohort median 256).
PRESCRIBING · PART D · 2024
Total Rx claims
19
Beneficiaries
—
Total drug cost
$147
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Pantoprazole Sodium19 claims
QUALITY · MIPS · 2024
Final MIPS score
77.6
Quality
66.9
Cost
71.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.11%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.